Cell Therapy Facility For DTM At NIH Clinical Center

In a bid to expand production capacity for clinical trials, the Department of Transfusion Medicine (DTM) at NIH required a cutting-edge cell therapy facility to produce treatments for patients with severe medical conditions, including cancer and autoimmune diseases. Tasked with this challenge, Germfree designed and constructed a state-of-the-art, 6,400 sq. ft. modular facility adhering to stringent cGMP cleanroom standards.

This innovative project utilized available space efficiently by incorporating a central utility plant atop the modules, thereby reducing the facility's overall footprint and ensuring cost-effectiveness. The result is a comprehensive cell therapy facility that supports advanced medical research and treatment at the NIH Clinical Center, exemplifying Germfree’s commitment to quality and safety in healthcare infrastructure.

Read on to learn how our innovative approach utilizing a full central utility plant and modular construction has advanced cellular therapy and improved patient outcomes.